Chemoinformaics analysis of Pterin-6-Carboxylic acid
| Molecular Weight | 207.149 | nRot | 1 |
| Heavy Atom Molecular Weight | 202.109 | nRig | 14 |
| Exact Molecular Weight | 207.039 | nRing | 2 |
| Solubility: LogS | -2.781 | nHRing | 2 |
| Solubility: LogP | -2.116 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 5 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 5 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 11 |
| nHA | 6 | APOL | 22.93 |
| nHD | 3 | BPOL | 10.172 |
| QED | 0.466 |
| Synth | 3.113 |
| Natural Product Likeliness | -0.321 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.736 |
| HIA | 0.014 |
| CACO-2 | -6.257 |
| MDCK | 0.0000076 |
| BBB | 0.14 |
| PPB | 0.498511 |
| VDSS | 0.386 |
| FU | 0.571116 |
| CYP1A2-inh | 0.017 |
| CYP1A2-sub | 0.944 |
| CYP2c19-inh | 0.035 |
| CYP2c19-sub | 0.032 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.003 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.022 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.08 |
| CL | 4.844 |
| T12 | 0.91 |
| hERG | 0.047 |
| Ames | 0.089 |
| ROA | 0.168 |
| SkinSen | 0.422 |
| Carcinogencity | 0.954 |
| EI | 0.354 |
| Respiratory | 0.981 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.578743 |